StonvexLoading…
StonvexStonvexStonvexCore line items from ARMK's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-10-03 | Annual 2024 2024-09-27 | Annual 2023 2023-09-29 | Annual 2022 2022-09-30 |
|---|---|---|---|---|
Revenue | $18.51B | $17.40B | $16.08B | $13.69B |
Operating Income | $791.85M | $706.51M | $625.03M | $415.39M |
Net Income | $326.39M | $262.52M | $674.11M | $194.48M |
EPS (Diluted) | $1.22 | $0.99 | $2.57 | $0.75 |
Total Assets | $13.30B | $12.67B | $16.87B | $15.08B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $639.10M | $672.48M | $1.93B | $305.72M |
Free Cash Flow OCF − CapEx | $431.80M | $299.09M | $382.89M | $382.55M |
Shares Outstanding | 262.90M | 263.94M | 261.45M | 258.73M |